Maxepa versus bezafibrate in hyperlipidemic cardiac transplant recipients
- 15 December 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 70 (20) , 1596-1601
- https://doi.org/10.1016/0002-9149(92)90463-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heartInternational Journal of Cardiology, 1991
- Serial evaluation of lipid profiles and risk factors for development of hyperlipidemia after cardiac transplantationThe American Journal of Cardiology, 1990
- Frequency of hypercholesterolemia after cardiac transplantationThe American Journal of Cardiology, 1988
- Accelerated coronary vascular disease in the heart transplant patient: Coronary arteriographic findingsJournal of the American College of Cardiology, 1988
- The fibrinolytic system and coagulation during bezafibrate treatment of hypertriglyceridemiaAtherosclerosis, 1986
- Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil FunctionNew England Journal of Medicine, 1985
- Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with HypertriglyceridemiaNew England Journal of Medicine, 1985
- Effect of bezafibrate during 4.5 years of treatment of hyperlipoproteinaemiaAtherosclerosis, 1985
- Comparative study of once and 3-times daily regimens of bezafibrate in patients with primary hyperlipoproteinaemiaCurrent Medical Research and Opinion, 1981
- The effect of bezafibrate on the fibrinolytic enzyme system and the drug interaction with racemic phenprocoumonAtherosclerosis, 1978